Avestar Capital’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$774K Buy
1,953
+149
+8% +$67.4K 0.05% 270
2025
Q4
$847K Sell
1,804
-380
-17% -$169K 0.05% 250
2025
Q3
$1.08M Sell
2,184
-177
-7% -$100K 0.07% 206
2025
Q2
$1.21M Buy
2,361
+871
+58% +$406K 0.08% 175
2025
Q1
$639K Sell
1,490
-434
-23% -$211K 0.06% 259
2024
Q4
$934K Buy
1,924
+372
+24% +$194K 0.08% 187
2024
Q3
$786K Sell
1,552
-20
-1% -$10.7K 0.08% 191
2024
Q2
$935K Buy
1,572
+349
+29% +$197K 0.1% 159
2024
Q1
$699K Buy
1,223
+191
+19% +$105K 0.07% 190
2023
Q4
$531K Buy
1,032
+211
+26% +$108K 0.06% 191
2023
Q3
$377K Buy
821
+99
+14% +$44.3K 0.05% 202
2023
Q2
$314K Buy
722
+37
+5% +$14.9K 0.05% 223
2023
Q1
$265K Buy
685
+9
+1% +$3.21K 0.05% 256
2022
Q4
$216K Sell
676
-12
-2% -$3.76K 0.04% 265
2022
Q3
$210K Buy
+688
New +$233K 0.05% 244

Other funds holding SNPS

Avestar Capital's SNPS Position: Q1 2026 in Review

Avestar Capital increased its Synopsys (SNPS) stake by 8.3% in Q1 2026, buying an estimated $67.4K and bringing the position to 1,953 shares worth $774K. The position accounts for 0.05% of the portfolio, ranked #270.

Avestar Capital first reported a position in SNPS in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.21M in Q2 2025. 1,390 funds tracked by Wall St. Rank hold SNPS as of Q1 2026.

  • Avestar Capital held 1,953 shares of Synopsys worth $774K as of Q1 2026.
  • Avestar Capital bought 149 Synopsys shares in Q1 2026, an estimated $67.4K.
  • Synopsys made up 0.05% of Avestar Capital's portfolio in Q1 2026, its #270 holding.
  • Avestar Capital first reported a position in Synopsys in Q3 2022 and has held it in 15 quarters since.
  • Avestar Capital's Synopsys position peaked at $1.21M in Q2 2025.
  • 1,390 funds tracked by Wall St. Rank held Synopsys as of Q1 2026.

Based on Avestar Capital's 13F filing for Q1 2026, filed 13 May 2026.